Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22266
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKontargiris, E.en
dc.contributor.authorKolettas, E.en
dc.contributor.authorVadalouca, A.en
dc.contributor.authorTrougakos, I. P.en
dc.contributor.authorGonos, E. S.en
dc.contributor.authorKalfakakou, V.en
dc.date.accessioned2015-11-24T19:23:14Z-
dc.date.available2015-11-24T19:23:14Z-
dc.identifier.issn1001-0602-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22266-
dc.rightsDefault Licence-
dc.subjectAmides/*toxicityen
dc.subjectApoptosis/drug effectsen
dc.subjectCell Lineen
dc.subjectCell Proliferation/drug effectsen
dc.subjectClusterinen
dc.subjectDose-Response Relationship, Radiationen
dc.subjectGlycoproteins/drug effects/*genetics/metabolismen
dc.subjectHumansen
dc.subjectKeratinocytes/drug effects/*metabolismen
dc.subjectMolecular Chaperones/drug effects/*genetics/metabolismen
dc.subjectProto-Oncogene Proteins c-bcl-2/drug effects/*genetics/metabolismen
dc.titleEctopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaineen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1038/sj.cr.7290242-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15538973-
heal.identifier.secondaryhttp://www.nature.com/cr/journal/v14/n5/pdf/7290242a.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2004-
heal.abstractLocal anesthetics inhibit cell proliferation and induce apoptosis in various cell types. Ropivacaine, a unique, novel tertiary amine-type anesthetic, was shown to inhibit the proliferation of several cell types including keratinocytes. We found that Ropivacaine could inhibit the proliferation and induce apoptosis in an immortalized human keratinocyte line, HaCaT, in a dose- and time-dependent manner and with the deprivation of serum. The dose-dependent induction of apoptosis by ropivacaine was demonstrated by DNA fragmentation analysis and the proteolytic cleavage of a caspase-3 substrate-poly (ADP-ribose) polymerase (PARP). In addition, ropivacaine downregulated the expression of clusterin/ apoliporotein J, a protein with anti-apoptotic properties, in a dose-dependent manner, which well correlated with the induction of apoptosis of HaCaT cells. To investigate the role of clusterin/apoliporotein J in ropivacaine-induced apoptosis, HaCaT cells overexpressing clusterin/apoliporotein J were generated and compared to cells expressing the well established anti-apoptotic Bcl-2 protein. Ectopic overexpression of the secreted form of clusterin/apoliporotein J or Bcl-2 decreased the sensitivity of HaCaT cells to toxic effects of ropivacaine as demonstrated by DNA fragmentation, the proteolytic cleavage of PARP and by a reduction in procaspase-3 expression. Furthermore, the downregulation of endogenous clusterin/apolipoprotein J levels by ropivacaine suggested that this might be one mechanism by which ropivacaine induced cell death in HaCaT cells. In conclusion, the ability of ropivacaine to induce antiproliferative responses and to suppress the expression of the anti-apoptotic protein clusterin/apolipoprotein J, combined with previously reported anti-inflammatory activity and analgesic property of the drug, suggests that ropivacaine may have potential utility in the local treatment of tumors.en
heal.journalNameCell Researchen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Kontargiris-2004-Ectopic expression o.pdf359.55 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons